BRCA1 and cancer: Patients had a mean age of 64.2 years, 6% (n = 26) were premenopausal, 15% (n = 63) had a known family history of BRCA1/2-related cancer, 80% (n = 325) had HR + /HER2− disease, and 20% (n = 82) had TNBC.